Brunei Darussalam vs Chad: The number of people with susceptibility test result for rifampicin
Brunei Darussalam
100
in 2021
Chad
100
in 2021
Brunei Darussalam rank
2nd
Chad rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Brunei Darussalam
- Chad
How they compare
Brunei Darussalam currently reports 100 against 100 in Chad, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Brunei Darussalam ahead.
Brunei Darussalam ranks 2nd and Chad ranks 2nd of 146 countries.
Brunei Darussalam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 12.46 | 87.54 | Brunei Darussalam |
| 2020s | 100 | 69.28 | 30.72 | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brunei Darussalam or Chad?
- Brunei Darussalam, at 100 against 100 in Chad as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brunei Darussalam and Chad?
- 0, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Chad?
- 5 years are reported by both, from 2017 to 2021.
- How do Brunei Darussalam and Chad rank globally for the number of people with susceptibility test result for rifampicin?
- Brunei Darussalam ranks 2nd and Chad ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.